What a vote on Grail’s cancer detection test could mean for the company, patients, and regulators

Inside Moderna and Merck’s cancer vaccine triumph

Moderna and Merck say mRNA cancer vaccine succeeded in late-stage melanoma trial

How we know that splitting up the MMR vaccine could be dangerous

In win for RFK Jr., FDA advisory panel narrowly votes to allow compounding of unapproved peptides

The quest to save Grace — and clear the way for rare disease patients everywhere

ARPA-H launches $160 million effort to develop custom gene editing drugs

The quest to save Grace — and clear the way for rare disease patients everywhere

Synthetic biology researchers think they’ve made a cell. Is it alive?

I spoke to Anthropic’s CEO about how AI may affect biotech. Here’s what I learned

Speaking Up: Who Is, and Who Isn't

Eli Lilly gave extraordinary obesity drug access to a 79-year-old patient. Who was it?

The Most Exciting Month of Medical Breakthroughs in Years

Springer Nature to divest its consumer media businesses | Springer Nature Group | Springer Nature

RFK Jr. claims his calendar is publicly available. We've been trying to get it for a year

For pancreatic cancer patients, an exciting drug can feel out of reach

STAT@ASCO: Science vs. Cancer

MIT president: Why so many optimistic scientists are losing heart

Why Marty Makary was the worst FDA commissioner in 25 years

An Early Look at mRNA Vaccines to Prevent Influenza | NEJM

Efficacy and Safety of an mRNA Seasonal Influenza Vaccine in Adults | NEJM

Remembering J. Craig Venter: a relentless scientist who changed biotech — and was all too easily misunderstood

How an outsider crept into Eli Lilly’s top ranks — and plans to drive its business forward

How a Texas couple is getting rich off out-of-network medical bills

5 lessons from Vinay Prasad's turbulent tenure at the FDA

The extremism of the FDA's Marks and Prasad has come with costs

FDA Commissioner Marty Makary defends rare disease drug rejections, Vinay Prasad

5 key people to watch at HHS after Trump’s shake-up

NIH Director Bhattacharya to lead CDC after O’Neill’s exit

Upcoming meeting of federal vaccine panel may be postponed after HHS missed deadlines

The FDA’s Moderna pirouette is one more sign of chaos at the agency

Statins don’t cause most of the side effects on package warnings, study finds

This ranks among the darkest days in the history of one of the world’s greatest news organizations. The Washington Post’s ambitions will be sharply diminished, its talented and brave staff will be… | ...

Genes influence human lifespan far more than thought, new study suggests

This Teen Never Got His Day in Vaccine Court. His Former Lawyer Now Advises RFK on Its Overhaul. - KFF Health News